Quercetin vs Fisetin: Best Senolytic for Longevity?

Mike HartnettEvidence-Based

7+ years researching longevity protocols. Runs a 20+ supplement daily stack. Built CoreStacks after losing his father to heart disease.

This article contains affiliate links. We may earn a commission at no extra cost to you.

Quercetin vs Fisetin at a Glance

What Is Quercetin?

Quercetin is a flavonoid you’re already eating. It’s in onions, apples, berries, green tea — it’s one of the most abundant flavonoids in the human diet. As a supplement, it’s been studied for decades across anti-inflammatory, antioxidant, antihistamine, and cardiovascular applications. The research base is deep.

Where things get interesting for the longevity crowd is senolytics. Dr. James Kirkland’s team at the Mayo Clinic pioneered the dasatinib + quercetin (D+Q) protocol — the first senolytic combination tested in humans. A 2019 pilot study published in EBioMedicine showed D+Q reduced senescent cell markers in patients with diabetic kidney disease. Here’s the catch though: quercetin alone is a relatively weak senolytic. It’s the dasatinib (a prescription leukemia drug) doing most of the heavy lifting in that combination.

That said, quercetin’s daily utility goes way beyond senolytics. Brad Stanfield has discussed its anti-inflammatory properties, and it’s a natural antihistamine that plenty of people use during allergy season instead of popping Zyrtec. At 500–1,000 mg per day, it’s also one of the cheaper flavonoids you can add to a stack. For how quercetin fits into broader expert protocols, check our expert stacks comparison.

What Is Fisetin?

Fisetin is found naturally in strawberries, apples, and persimmons — but in tiny amounts. You’d need to eat about 37 strawberries to get even a modest supplemental dose. As a supplement, it’s the newer player, and the senolytic data is what’s generating all the excitement.

The big moment for fisetin was a 2018 study from the Kirkland lab at Mayo Clinic, published in EBioMedicine. They tested 10 different flavonoids for senolytic activity, and fisetin came out on top. In aged mice, it reduced senescent cell burden, decreased inflammatory markers, and extended both median and maximum lifespan. The critical detail: fisetin did this as a single agent. No prescription drug combo needed.

The Mayo Clinic is now running the AFFIRM-LITE trial — a randomized controlled trial testing fisetin in older adults. This is the study the longevity community is waiting on. David Sinclair has mentioned fisetin as a compound worth watching, and it shows up regularly in discussions on r/longevity. Some people run intermittent high-dose protocols — 1,500 to 2,000 mg for two to three consecutive days per month — mimicking the senolytic burst approach from research. For how senolytics fit into the bigger longevity picture, see our Sinclair protocol breakdown.

Key Differences Between Quercetin and Fisetin

Senolytic potency is the headline difference. In the Kirkland lab’s direct comparison, fisetin outperformed quercetin as a standalone senolytic — and it wasn’t close. Quercetin needs dasatinib to produce meaningful senescent cell clearance. Fisetin does the job alone. If your primary goal is clearing zombie cells, fisetin is the obvious pick based on available preclinical data.

Breadth of evidence favors quercetin by a wide margin. Quercetin has hundreds of human clinical trials across inflammation, immune function, cardiovascular health, and allergy management. Fisetin’s human data is still thin — we’re essentially waiting on AFFIRM-LITE and a handful of smaller trials. Quercetin is a known quantity. Fisetin is a promising bet. There’s a real difference between those two things.

Dosing protocols are fundamentally different. Most people take quercetin daily at 500–1,000 mg for general health benefits. Fisetin is increasingly used in intermittent high-dose bursts for senolytic purposes — the logic being that senescent cells don’t repopulate quickly, so periodic clearance every few weeks is sufficient. Some people do take low-dose fisetin daily, but the senolytic research points toward periodic high-dose protocols.

Both have bioavailability problems. Neither compound absorbs particularly well in standard form. Quercetin phytosome and bromelain-enhanced formulations help. For fisetin, liposomal formulations and Novusetin (a branded form) are the go-to options for better absorption. Whatever you choose, standard powder-in-capsule forms are probably leaving a lot on the table. For budget-friendly stack options, see our longevity stack under $100 guide.

Can You Stack Quercetin and Fisetin?

You can, and some longevity-focused people do. Since both are flavonoids with overlapping but not identical mechanisms, combining them for senolytic protocols is a reasonable approach. The idea is that quercetin adds anti-inflammatory support while fisetin does the heavier senolytic work.

That said, the combined effect hasn’t been specifically studied. And with senolytics, more aggressive isn’t necessarily better — senescent cells do play some short-term roles in wound healing and tissue repair, so nuking them too aggressively could theoretically cause problems. The responsible approach is to start with one, assess how you respond, and then consider adding the second. There are no known negative interactions between the two compounds. If you’re running other supplements alongside these, check our interaction checker to verify your full stack.

What Experts Say

Dr. James Kirkland’s lab at the Mayo Clinic is responsible for most of the foundational research on both compounds. His work established dasatinib + quercetin as the first human senolytic protocol and identified fisetin as the most potent flavonoid senolytic in preclinical testing. The AFFIRM-LITE trial is his team’s effort to validate fisetin in humans.

David Sinclair has discussed senolytics broadly and has mentioned fisetin as a promising longevity compound, though his personal protocol focuses more on NMN and resveratrol. Brad Stanfield has covered both compounds on his YouTube channel, generally taking a measured stance — acknowledging the exciting preclinical data while noting the lack of definitive human trials for senolytic benefits. His position aligns with what you’d expect from evidence-based analysis: promising, but not proven yet. For more on the rapamycin angle of longevity research, see our rapamycin research guide.

Which Should You Choose?

Choose quercetin if you want a well-studied daily supplement with broad anti-inflammatory, antihistamine, and cardiovascular benefits. It’s cheaper, it has decades of human safety data, and it does a lot of things competently. If you suffer from seasonal allergies, quercetin is pulling double duty.

Choose fisetin if your primary interest is senolytic cell clearance and you’re comfortable being an early adopter. The preclinical data is genuinely impressive — more potent than quercetin alone, no prescription drug needed. But you’re betting on emerging science, and the human trial data isn’t in yet. Also budget about twice as much per month.

if you’re already running a longevity stack and want to add a senolytic component, fisetin is the more targeted choice. If you’re building a general wellness stack and want a flavonoid that does a bit of everything, quercetin is the more practical pick. And if you want to compare both against spermidine (another popular longevity compound), check our spermidine vs fisetin comparison. Either way, consider getting baseline bloodwork first — see our guide on whether you need blood work before supplements.

Frequently Asked Questions

Related Comparisons

Looking for more supplement comparisons? Check out our resveratrol vs quercetin.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.